Tacrolimus/Cyclosporine
Schisandra increased tacrolimus AUC by 164% and Cmax by 227%. Potentially fatal in transplant patients.
Recommendation: Do NOT combine. Schisandra dramatically increases immunosuppressant levels.
Herb ·Moderate evidence ·Reviewed May 2026
Adaptogenic berry used in TCM for liver protection and stress resilience.
The bottom line
Evidence rating moderate. Most-documented uses: liver protection, stress adaptation, endurance. 19 sources indexed (2008–2026), with 10 interaction records on file.
Core mechanism
Lignans such as schisandrin B influence oxidative stress, mitochondrial function, and hepatic glutathione. Schisandra lignans can also inhibit or modulate CYP450 enzymes and P-glycoprotein, creating clinically relevant drug-interaction potential.11,15
Dosing protocol
Inhibits CYP3A4; counsel on drug interactions. Best evidence for hepatic support.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Standardized Schisandra Extract.
Assumes 500-1,000 mg/day. Vendor basis: NOW/iHerb, Vitacost, Amazon marketplace, and specialty herb brands; schisandrin-standardized extracts cost more. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Extracts may standardize lignans more tightly than whole berries.
What to test, the optimal window inside the conventional range, and how long a response takes.
Schisandra chinensis lignans (schizandrin and gomisin) lower ALT and AST modestly in chronic hepatitis RCTs; mechanism includes induction of phase II detox enzymes.11,12
Pair with AST and GGT. Schisandra inhibits CYP3A4; counsel on potential drug interactions.
Schisandra is expected to modestly lower AST in chronic liver conditions, with effects that are typically small, dose-dependent, and most apparent when AST is elevated at baseline.1,18
Hold strenuous exercise and alcohol for 48 hours before the draw to avoid false elevations, and test at a consistent time. AST alone is nonspecific, so interpret alongside ALT. Retest at about 3 months.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Schisandra lignans support hepatocyte regeneration and reduce ALT in chronic hepatitis; inhibits CYP3A4 with drug interaction implications.11,12
Schisandra (Schisandra chinensis) is a traditional adaptogen investigated for effects on stress mediators and physical and mental performance, often as part of combination formulas. Human evidence specific to stress resilience is still emerging and largely preliminary.12,13
Schisandra increased tacrolimus AUC by 164% and Cmax by 227%. Potentially fatal in transplant patients.
Recommendation: Do NOT combine. Schisandra dramatically increases immunosuppressant levels.
Schisandra lignans and milk thistle silymarin both support hepatocyte protection and antioxidant defense, giving complementary hepatoprotective effects.
Recommendation: Commonly used together for liver support. If on drugs with a narrow therapeutic window, monitor because both can influence hepatic enzyme activity.
Schisandra and NAC both raise hepatic glutathione and antioxidant capacity, providing complementary protection against oxidative liver stress.
Recommendation: Reasonable combination for antioxidant and liver support. No specific separation required.
Schisandra and Rhodiola are both adaptogens that modulate the stress response and reduce fatigue, with traditional and clinical use of the combination for endurance and mental performance.
Recommendation: Commonly combined as adaptogens. Take earlier in the day since both can be mildly stimulating and may affect sleep if taken late.
Schisandra and ashwagandha are both adaptogens that help regulate the stress axis and lower perceived stress, with complementary calming and resilience effects.
Recommendation: Reasonable adaptogen combination for stress support. Monitor for excess sedation when stacking multiple adaptogens.
Schisandra extract has human evidence of inhibiting CYP3A activity, and methylprednisolone exposure is highly sensitive to CYP3A inhibition. Combining them could raise steroid exposure and increase systemic adverse effects such as mood changes, high glucose, fluid retention, and adrenal suppression.
Recommendation: Avoid starting high-dose Schisandra during methylprednisolone therapy unless your prescriber knows. If the combination is used, monitor for stronger steroid effects and do not abruptly stop methylprednisolone after prolonged use.
Schisandra extract can inhibit CYP3A in humans, and dexamethasone exposure rises markedly when CYP3A4 is inhibited. Adding Schisandra could increase dexamethasone effects, including insomnia, mood changes, glucose elevation, and adrenal suppression.
Recommendation: Avoid adding Schisandra during dexamethasone therapy unless your prescriber is aware, especially with repeated or high-dose courses. Watch for stronger steroid side effects and ask about dose adjustment if Schisandra is continued.
Schisandra extract inhibits CYP3A in human pharmacokinetic studies. Budesonide is normally cleared extensively by CYP3A, so inhibition can raise systemic steroid exposure even when budesonide is inhaled, especially at higher doses or with prolonged use.
Recommendation: Avoid adding high-dose Schisandra to inhaled budesonide without clinician review. Monitor for unusual steroid effects such as easy bruising, facial swelling, high glucose, or symptoms of adrenal suppression, but do not stop the inhaled steroid abruptly.
Schisandra has human evidence of CYP3A inhibition, and fluticasone is highly dependent on CYP3A metabolism. Strong CYP3A inhibition has caused adrenal suppression and Cushing syndrome with inhaled fluticasone, so Schisandra could increase systemic steroid exposure in high-risk use.
Recommendation: Do not add concentrated Schisandra extract to chronic or high-dose inhaled fluticasone without clinician review. Monitor for easy bruising, facial rounding, weight gain, high glucose, or fatigue that could suggest adrenal suppression.
Nasal fluticasone usually has low systemic exposure, but CYP3A inhibition can still increase steroid exposure in susceptible patients. Schisandra extract inhibits CYP3A in humans, so concentrated products may increase the risk of systemic steroid effects during chronic nasal fluticasone use.
Recommendation: Use Schisandra cautiously if you use nasal fluticasone daily or at high doses. Watch for steroid excess symptoms such as easy bruising, facial swelling, weight gain, or unusual fatigue, and tell your clinician about the supplement.
Numbered references. Citations throughout the page link here.
54 animal studies showed schisandra bioactive compounds significantly reduced ALT, AST, and ALP levels, confirming hepatoprotective effects
RCT of 80 participants with hyperglycemia found 12 weeks of Omija/Schisandra extract mixture significantly decreased fasting plasma glucose, postprandial glucose, fructosamine, and LDL cholesterol compared to placebo.
RCT of 54 adults >50 years found 12 weeks of Schisandra chinensis extract (1 g/day) significantly increased right knee extensor strength (+10.2 Nm) and left knee extensor strength (+6.7 Nm) compared to placebo, without adverse events.
RCT of 45 post-menopausal women found 12 weeks of SC extract (1000 mg/day) significantly increased quadriceps muscle strength and decreased resting lactate levels.
RCT of 36 menopausal women found Schisandra chinensis extract (BMO-30) significantly reduced total Kupperman Index scores compared to placebo, especially for hot flushes, sweating, and heart palpitations.
Song MY, Wang JH, Eom T et al.. Schisandra chinensis fruit modulates the gut microbiota composition in association with metabolic markers in obese women: a randomized, double-blind placebo-controlled study. Nutrition research (New York, N.Y.). 2015
Liu Z, Wang C, Fan H et al.. Modulation of disease-associated gut microbiota by Schisandra chinensis: a literature review. Frontiers in pharmacology. 2026
Zheng A, Yang D, Pan C et al.. Modeling the complexity of drug-drug interactions: A physiologically-based pharmacokinetic study of Lenvatinib with Schisantherin A/Schisandrin A. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2024
Valíčková J, Zezulka Š, Maršálková E et al.. Potential toxicity of Schisandra chinensis to water environment: acute toxicity tests with water crustaceans. Environmental science and pollution research international. 2023
Zhang F, Zhai J, Weng N et al.. A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities. Frontiers in pharmacology. 2022
Schisandra lignans, including schisandrin B, exhibit potent antioxidant properties that protect against oxidative stress and enhance hepatic glutathione
Schisandra lignans have confirmed adaptogenic effects, central nervous system stimulation, hepatoprotective effects, and potential anticancer properties
Schisandra chinensis gained recognition as an adaptogen in official USSR medicine, with clinical trials demonstrating efficacy in asthenia, neuralgic and psychiatric disorders, and influenza
Schisandrin B provides cytoprotection against oxidative stress via Nrf2/Keap1 pathway modulation, supporting its use as an adaptogenic compound
Schisandrin B supplementation suppressed mitochondrial ROS production, enhanced mitochondrial ATP generation, and improved survival in aging mice
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.